Abstract
In the past two decades, interest in the Tumor Microenvironment (TME) has surged due to the increased acknowledgment of impact of non-neoplastic cells and extracellular matrix on the initiation, progression, treatment response and therapeutic resistance of solid tumors. Recently, research in tumor immunology yielded novel therapeutic approaches incorporated into the clinical management. T…